Why the study?
Heart disease remains a major global cause of mortality despite available strategies, prompting evaluation of exosomes as emerging agents in cardiac pathogenesis, diagnosis, prognosis, and therapy.
Answers are grounded in this paper and cite their sources.
This review highlights the emerging potential of exosomes as diagnostic biomarkers and therapeutic agents in regenerative cardiology.
Heart diseases are the primary cause of mortality and morbidity worldwide which inflict a heavy social and economic burden. Among heart diseases, most deaths are due to myocardial infarction (MI) or heart attack, which occurs when a decrement in blood flow to the heart causes injury to cardiac tissue. Despite several available diagnostic, therapeutic, and prognostic approaches, heart disease remains a significant concern. Exosomes are a kind of small extracellular vesicles released by different types of cells that play a part in intercellular communication by transferring bioactive molecules important in regenerative medicine. Many studies have reported the diagnostic, therapeutic, and prognostic role of exosomes in various heart diseases. Herein, we reviewed the roles of exosomes as new emerging agents in various types of heart diseases, including ischemic heart disease, cardiomyopathy, arrhythmia, and valvular disease, focusing on pathogenesis, therapeutic, diagnostic, and prognostic roles in different areas. We have also mentioned different routes of exosome delivery to target tissues, the effects of preconditioning and modification on exosome's capability, exosome production in compliance with good manufacturing practice (GMP), and their ongoing clinical applications in various medical contexts to shed light on possible clinical translation.
No takes yet. Share an insight, caveat, or question.
Ahmadi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: